Use of Cannabinoids in Alzheimer's Disease: integrative Synthesis of the Literature
Introduction: Alzheimer's disease (AD) is an incurable neurodegenerative condition with limited therapeutic options. Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), derived from Cannabis sativa, show therapeutic potential due to their neuroprotective properties and interaction with the endocannabinoid system (ECS). Objectives: Synthesize and evaluate the available scientific evidence on the use of cannabinoids in the treatment of AD.